We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
[Product Name]: L-Proline
[CAS]: 147-85-3
[Molecular Formula]: C5H9NO2
[Molecular Weight]: 115.13
[EINECS]: 205-702-2
[Chemical Properties]: Colorless crystal, odorless, sweet taste. Freely soluble in water and ethanol, insoluble in butanol and ether. When hydrated with indene, the test solution is yellow and glacial acetic acid is red acidification.
[Quality Standard]: AJI, USP, FCC
[Usage]:
1、As amino acids can supply nutrients. It's the raw material of amino acid infusion, used for the supplement of malnutrition, protein deficiency, gastroinstestinal diseases scald and postoperative protein, etc.
2、It has curative effect on hypertension and is an important intermediate for the synthesis of catopril, enalapril and other first-line antihypertensive drugs;
3、Amino acid-carboxyl group reaction occurs between L-Proline and sugar;
4、As a nutritional supplement, tissue resistance can be improved and survival rate of callus can be increased.
[Package]: 25kg/bag, 25kg/drum, or as requested.
[Transportation]: Handle care to avoid damaging package;
Do not transport together with poisonous or harmful substances.
[Storage]: Store in a cool and dry place.
Two years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
